On November 3rd, Jiangsu Hengrui Pharmaceuticals(01276) spent 6.3223 million yuan to repurchase 100,000 A shares.
Hengrui Medicine (01276) announced the repurchase of 100,000 shares of A... for 6.3223 million yuan on November 3, 2025.
Jiangsu Hengrui Pharmaceuticals (01276) announced that on November 3, 2025, it spent 6.3223 million yuan to repurchase 100,000 shares of A shares.
Related Articles
US Stock Market Move | Uxin Ltd. Sponsored ADR (UXIN.US) surged more than 17%, reaching a strategic cooperation agreement with Guangzhou Development Zone to build a comprehensive automotive industry complex.
US Stock Market Move | NIO Inc. Sponsored ADR Class A (NIO.US) rose more than 2% in October, with new car deliveries increasing by 92.6% year-on-year.
TA YANG GROUP (01991) is making a potential strategic investment in the CoinVEX platform for Real World Assets (RWA) services.
US Stock Market Move | Uxin Ltd. Sponsored ADR (UXIN.US) surged more than 17%, reaching a strategic cooperation agreement with Guangzhou Development Zone to build a comprehensive automotive industry complex.
US Stock Market Move | NIO Inc. Sponsored ADR Class A (NIO.US) rose more than 2% in October, with new car deliveries increasing by 92.6% year-on-year.
TA YANG GROUP (01991) is making a potential strategic investment in the CoinVEX platform for Real World Assets (RWA) services.
